ArticleBMJ open2026
Cardiovascular disease risk perception and stages of preventive behaviours: a community survey in Pokhara Metropolitan, Nepal.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesCardiovascular diseases (CVDs) are a leading cause of mortality in Nepal. Risk perception is crucial for the prevention of CVD-related behaviours. This study assessed CVD risk perceptions and the stages of preventive behaviours among adults in Pokhara Metropolitan, Nepal by integrating two theoretical models-the Health Belief Model and the Transtheoretical Model.
designThis study used a cross-sectional design with data collected through a survey using a semistructured questionnaire.
settingThis study was conducted from July 2024 to August 2024; among community people aged ≥20 residing in 11 wards of Pokhara Metropolitan.
participantsA total of 384 community people residing in Pokhara Metropolitan, Nepal. PRIMARY OUTCOME AND EXPLANATORY VARIABLES: The primary outcome measure was stage of preventive behaviours of CVDs using Fuster BEWAT components (blood pressure, exercise, weight, diet and tobacco), while explanatory variables were sociodemographic characteristics and CVD Health Beliefs.
resultsA total of 384 adults participated (response rate=95%). The mean age was 42.3 years (SD±14.5), with equal representation of males and females. More than half of the participants (55.5%) perceived low susceptibility to CVDs, 40.4% perceived high severity, 78.4% perceived high benefits and 49.5% perceived moderate barriers. Most respondents were in the precontemplation stage for blood pressure control (43%) and weight management (30.5%), whereas maintenance was most common for physical activity (41.1%), healthy diet (51.3%) and smoking abstinence (80.1%).Ordinal logistic regression revealed that low perceived benefits significantly hindered behavioural progression (p=0.001-0.012), where low perceived barriers significantly facilitated advancement across all behaviours (p<0.05). The association for perceived susceptibility and severity was inconsistent. Overall, enhancing perceived benefits and reducing barriers were the strongest predictors of progression through stages of change in CBD preventive behaviours.
conclusionsPerceived benefits and barriers were key predictors of progression in CVD prevention behaviours. While many adults maintained healthy diets, physical activity and smoking abstinence, most were in the early stage for blood pressure and weight control strategies. Strengthening perceived benefits and reducing barriers can enhance the adoption of healthy behaviours in Nepal.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.